Ben Stiller reveals he was diagnosed with 'aggressive' form of disease and has had his prostate removed after calling Robert De Niro

Your treatment options will depend on whether your cancer is contained within the prostate gland (localised), has spread just outside of the prostate (locally advanced) or had spread to other parts of the body (advanced).

You may have a choice of treatments. Your doctor or specialist nurse will explain all your treatment options, and help you to choose the right treatment for you.

Scientists in the capital are developing a blood test that could save hundreds of thousands of men a year from painful biopsies to test for prostate cancer...

Researchers found invasive treatments for early stage prostate cancer, such as surgery, didn't help people live any longer when compared to active surveillance.

The STAMPEDE trial is a multi-arm, multi-stage trials platform testing a range of different therapies in addition to standard of care (SOC) for men commencing long term androgen deprivation therapy (ADT) for newly diagnosed locally advanced or metastatic prostate cancer. These data from the control arm form part of a pair of publications detailing outcomes in the control arm of STAMPEDE and help to make sense of the forthcoming paper on the randomised comparisons currently in press at the Lancet.

he much-awaited results of a large randomised trial comparing three approaches to localised prostate cancer were published in The New England Journal of Medicine today. Strikingly, the treatment approach didn’t make a difference to 10-year survival: 99% of the more than 1600 men in the trial were alive after a decade...

By 2030 Prostate cancer will be the most common of all cancers in the UK. We take a look at the signs and symptoms and what you should eat..

A radioactive prostate cancer drug has been recommended for routine NHS use following a decision by the National Institute for Health and Care Excellence (Nice). Radium-223 dichloride, marketed as Xofigo, could be made available for treating prostate cancer patients as early as December.

Thousands of men with early prostate cancer needlessly undergo gruelling surgery and radiotherapy, a study suggests. Men are just as likely to survive for ten years if they go for regular check-ups rather than rushing into treatment, the research found. The decade-long study led by Oxford and Bristol universities shows men with localised prostate cancer may not have to endure treatment and its side effects.